Who’s Using GLP-1 Medications? Study Finds Major Shift in Patient Population
A new study finds GLP-1 medications like Ozempic and Wegovy are now being prescribed more often for obesity than type 2 diabetes.
Health News is provided as a service to Nipomo Rexall Drug site users by HealthDay. Nipomo Rexall Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.